Martin Shkreli, the most hated man on the Internet, regrets that he jacked up the price of the off-patent drug Daraprim, taken mainly by people with AIDS and cancer, by a mere 5,000%.
He says that "I could have raised it higher and made more profits for our shareholders, which is my primary duty."
But at Thursday's summit, Shkreli was painfully clear: His job isn't making patients better. It's making the most dollars.
"My shareholders expect me to make the most profit," Shkreli said, a theme that he returned to again and again. "That's the ugly, dirty truth."
"I'm going to maximize profits," Shkreli added later. "That's what people [in healthcare] are afraid to say."
Martin Shkreli Admits He Messed Up: He Should've Raised Prices Even Higher